Evid Invest
Who owns VRTXWhat VRTX owns — n/a

Who owns VERTEX PHARMACEUTICALS INC / MA?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of VRTX from SEC Form 13F filings across 1,786 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 1,786 institutions disclosed 239.0M shares of VERTEX PHARMACEUTICALS INC / MA worth $125.02B — about 94.3% of shares outstanding; the largest disclosed holder is Capital World Investors. Source: SEC Form 13F filings, parsed by EvidInvest.

1,786

13F holders

$125.02B

value, 2026 filers

94.3%

of shares outstanding (239.0M sh)

176

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of VRTX's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1Capital World Investors26.0M$13.58B1.6%10.2%-0.6%
2BlackRock, Inc.23.8M$12.44B0.2%9.4%-1.3%
3Capital Research Global Investors17.8M$9.31B1.3%7%-8.6%
4VANGUARD CAPITAL MANAGEMENT LLC16.6M$8.68B0.2%6.5%+0.1%
5STATE STREET CORP12.0M$6.29B0.2%4.7%+1.3%
6Invesco Ltd.8.3M$4.33B0.3%3.3%+3.0%
7GEODE CAPITAL MANAGEMENT, LLC6.1M$3.17B0.2%2.4%+1.1%
8JPMORGAN CHASE & CO5.7M$3.00B0.2%2.2%-12.7%
9Capital International Investors5.1M$2.65B0.5%2%+7.8%
10VANGUARD PORTFOLIO MANAGEMENT LLC4.9M$2.59B0.1%2%+1.3%
11FRANKLIN TEMPLETON INC4.5M$2.45B0.5%1.8%+33.3%
12LOOMIS SAYLES & CO L P3.6M$1.89B2.5%1.4%-7.7%
13JENNISON ASSOCIATES LLC3.6M$1.87B1.1%1.4%+19.2%
14UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC3.4M$1.80B0.3%1.4%+11.4%
15WELLINGTON MANAGEMENT GROUP LLP3.4M$1.76B0.3%1.3%+3.6%
16MORGAN STANLEY3.3M$1.71B0.1%1.3%+1.1%
17BANK OF AMERICA CORP /DE/3.1M$1.64B0.1%1.2%+2.9%
18ALLIANCEBERNSTEIN L.P.3.0M$1.57B0.5%1.2%-0.3%
19NORTHERN TRUST CORP2.6M$1.34B0.2%1%+3.2%
20VICTORY CAPITAL MANAGEMENT INC2.6M$1.34B0.7%1%+17.7%
21AMERIPRISE FINANCIAL INC2.3M$1.18B0.2%0.9%-13.1%
22GOLDMAN SACHS GROUP INC2.2M$1.15B0.1%0.9%-11.3%
23CHARLES SCHWAB INVESTMENT MANAGEMENT INC1.9M$981.1M0.1%0.7%-8.1%
24Legal & General Group Plc1.8M$964.3M0.2%0.7%-1.4%
25PRICE T ROWE ASSOCIATES INC /MD/1.7M$906.2M0.1%0.7%+0.3%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.